ICU Medical (ICUI) Tops Q2 EPS Views; Boosts FY15 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
Roth Capital Raises Price on ICU Medical (ICUI) to $124 Following 2Q EPS Beat and Raise
August 11, 2015 8:17 AM EDTRoth Capital reiterated a Buy rating on ICU Medical (NASDAQ: ICUI), and raised the price target to $124.00 (from $102.00), following the company's 2Q earnings release. 2Q revenues of $83.8 million beat Street's $78.89 million estimate. Adjusted EPS of $0.97 beat Street's $0.69. ICUI raised its annual outlook, which... More



